Overall Survival After Mohs Surgery for Early-Stage Merkel Cell Carcinoma
Authors:
- 1 October 2023
- journal article
- research article
- Published by American Medical Association (AMA) in JAMA Dermatology
- Vol. 159 (10) , 1068-1075
Abstract
Importance: Merkel cell carcinoma (MCC) is a rare cutaneous malignant neoplasm with increasing incidence and high mortality. Although it is accepted that the optimal treatment for localized tumors is surgical, the data surrounding the optimal surgical approach are mixed, and current National Comprehensive Cancer Network guidelines state that Mohs micrographic surgery (MMS) and wide local excision (WLE) can both be used. The current National Comprehensive Cancer Network guidelines do not advocate a preference for MMS or WLE and suggest that they can be used interchangeably.Objective: To evaluate the association of surgical approach with overall survival after excision of localized T1/T2 MCC.Design, Setting, and Participants: This retrospective cohort study used the National Cancer Database to assess adults with T1/T2 MCC who were diagnosed between January 1, 2004, and December 31, 2018, with pathologically confirmed, negative regional lymph nodes and treated with surgery. The National Cancer Database includes all reportable cases from Commission on Cancer–accredited facilities. Data analysis was performed from October 2022 to May 2023.Exposure: Surgical approach.Main Outcomes and Measures: Overall survival.Results: A total of 2313 patients (mean [SD] age, 71 [10.6] years; 1340 [57.9%] male) were included in the study. Excision with MMS had the best unadjusted survival, with mean (SE) survival rates of 87.4% (3.4%) at 3 years, 84.5% (3.9%) at 5 years, and 81.8% (4.6%) at 10 years vs 86.1% (0.9%) at 3 years, 76.9% (1.2%) at 5 years, and 60.9% (2.0%) at 10 years for patients treated with WLE. Patients treated with narrow-margin excision had similar survival as those treated with WLE, with mean (SE) survival rates of 84.8% (1.4%) at 3 years, 78.3% (1.7%) at 5 years, and 60.8% (3.6%) at 10 years. On multivariable survival analysis, excision with MMS was associated with significantly improved survival compared with WLE (hazard ratio, 0.59; 95% CI, 0.36-0.97; P = .04). High-volume MCC centers were significantly more likely to use MMS over WLE compared with other centers (odds ratio, 1.99; 95% CI, 1.63-2.44; P < .001).Conclusions and Relevance: In this cohort study, the use of MMS (compared with WLE) was associated with significantly improved survival for patients with localized MCC with pathologically confirmed negative lymph nodes treated with surgery. These data suggest that Mohs surgery may provide a more effective treatment for MCC primary tumors than conventional WLE, although the lack of randomization and potential for selection bias in this study highlight the need for future prospective work evaluating this issue.Keywords
This publication has 43 references indexed in Scilit:
- Prognostic factors in Merkel cell carcinoma: Analysis of 240 casesJournal of the American Academy of Dermatology, 2013
- Mohs Micrographic Surgery and Surgical Excision for Nonmelanoma Skin Cancer Treatment in the Medicare PopulationArchives of Dermatology, 2012
- Mohs Surgery for Squamous Cell CarcinomaDermatologic Clinics, 2011
- The National Cancer Data Base: A Powerful Initiative to Improve Cancer Care in the United StatesAnnals of Surgical Oncology, 2008
- Basal cell carcinoma treated with Mohs surgery in Australia II. Outcome at 5-year follow-upJournal of the American Academy of Dermatology, 2005
- Epidemiology of primary Merkel cell carcinoma in the United StatesJournal of the American Academy of Dermatology, 2003
- Local control of primary Merkel cell carcinoma: Review of 45 cases treated with Mohs micrographic surgery with and without adjuvant radiationJournal of the American Academy of Dermatology, 2002
- The importance of postoperative radiation therapy in the treatment of Merkel cell carcinomaInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 1995
- Prognostic factors for local recurrence, metastasis, and survival rates in squamous cell carcinoma of the skin, ear, and lipJournal of the American Academy of Dermatology, 1992
- A new look at the statistical model identificationIEEE Transactions on Automatic Control, 1974